Minireview. Presynaptic receptors and alterations in norepinephrine release in spontaneously hypertensive rats.
The ability of blood vessels to constrict to a given stimulus is significantly increased in spontaneously hypertensive rats (SHR). Such an increase in the vasoconstrictor responsiveness contributes to the elevated peripheral vascular resistance noted in SHR. The present review discusses evidence in support of the concept that an increased release of norepinephrine during sympathetic nerve stimulation may contribute to the increase in vasoconstrictor responsiveness and, subsequently, to an increase in vascular resistance in the SHR. Several studies suggest that the exocytotic release of norepinephrine from sympathetic nerves may be altered by endogenously occurring neurohumoral substances which produce their effects by interacting with presynaptic receptors located on postganglionic sympathetic nerves. Therefore, it is postulated that alterations in presynaptic regulation of norepinephrine release, resulting from changes in the functioning of one or more of these presynaptic receptors, may lead to a greater release of norepinephrine in the SHR. This review summarizes the results of studies evaluating presynaptic receptor mechanisms and norepinephrine release in the SHR. These studies suggest that norepinephrine release during sympathetic nerve stimulation is greater in the SHR and that alterations in some of the presynaptic receptor mechanisms may be responsible for this phenomenon.
D000241:Adenosine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001808:Blood Vessels / Q000503:physiopathology; D002118:Calcium / Q000494:pharmacology; D015232:Dinoprostone; D005089:Exocytosis / Q000187:drug effects; D006973:Hypertension / Q000503:physiopathology*; D009638:Norepinephrine / Q000378:metabolism*; D011458:Prostaglandins E / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains / Q000502:physiology*; D011942:Receptors, Adrenergic, alpha / Q000502:physiology; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D011945:Receptors, Angiotensin / Q000502:physiology; D011956:Receptors, Cell Surface / Q000502:physiology; D011982:Receptors, Prostaglandin / Q000502:physiology; D011983:Receptors, Purinergic; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology; D013569:Synapses / Q000502:physiology*; D014655:Vascular Resistance; D014661:Vasoconstriction
D011458:Prostaglandins E; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D011945:Receptors, Angiotensin; D011956:Receptors, Cell Surface; D011982:Receptors, Prostaglandin; D011983:Receptors, Purinergic; D000804:Angiotensin II; D000241:Adenosine; D015232:Dinoprostone; D002118:Calcium; D009638:Norepinephrine